Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-03

Clinical Trial Update: Effect of Melatonin on Seizure Outcome, Neuronal Damage and Quality of Life in Patients With Generalized Epilepsy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the impact of melatonin on seizure outcomes, neuronal damage, and quality of life in patients with generalized epilepsy is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: All India Institute of Medical Sciences, Bhubaneswar | Conditions: Generalized Epilepsy | Phase 4 | Status: COMPLETED